drugset / Trial / NCT03115047

Shivering Treatment After Cesarean Delivery: Meperidine vs. Dexmedetomidine

NCT03115047

Phase 3 Completed 80 enrolled University of Montreal Hospital Centre (CHUM)
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Comparing two treatments for shivering after cesarean delivery for labor dystocia under epidural anesthesia.

Timeline

Start
2017-05-07
Primary completion
2020-08-19
Completion
2020-08-20

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.35 ug/kg Intravenous
Comparator Meperidine Unknown 0.35 mg/kg Intravenous

Indications

No indication recorded.